The federal government has reached a deal to pay $3.2 billion to secure a new supply of the Pfizer/BioNTech Covid-19 vaccine that includes shots specifically adapted to the omicron variant that is now dominant. The agreement announced late Wednesday covers the purchase of 105 million doses. The government also has the option to buy up to 300 million more […]
